A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks

Sponsor
Botanee Group Co., Ltd. (Industry)
Overall Status
Completed
CT.gov ID
NCT05908903
Collaborator
(none)
70
1
2
29
73.5

Study Details

Study Description

Brief Summary

The main objective of the study is to observe changes in the subjects' sleep quality, skin condition and life status after 4 weeks of using a sleep aid drink (AOXMED Poria γ-aminobutyric acid drink).

This is a single-center, randomized, double-blind, controlled, 4-week (28-day) clinical study conducted in Chinese healthy women aged 25-55 years old who were offered a sleep aid drink.

Condition or Disease Intervention/Treatment Phase
  • Combination Product: Drinks with active ingredients such as poria and GABA
N/A

Detailed Description

The study population is 70 healthy Chinese women aged 25-55 years with a PSQI ≥ 7 (presence of sleep disorder) who report current problems with dryness, roughness, dullness and lack of elasticity on their face. The subjects will be randomly divided into an experimental group and a control product group of 35 subjects each, and the distribution of age and total hours of sleep will be more or less equal in both groups.

Subjects will be formally enrolled after on-site assessment and will undergo follow-up site visits and test product administration. During the test cycle, subjects in the experimental group will take a drink with the active ingredients of Poria, Poria and GABA, and subjects in the control product group will take a control drink without Poria, Date Palm and GABA ingredients for 4 weeks. To avoid the influence of different skincare products on the results, all subjects will be asked to use the basic skincare products with only moisturizing ingredients provided by the sponsor during the test period. The efficacy of the test products will be verified by comparing the changes in sleep quality, skin condition and life status of the subjects before and after taking the test products for 2 and 4 weeks, and by comparing the differences in sleep quality, skin condition and life status between the test and control groups.

Study Design

Study Type:
Interventional
Actual Enrollment :
70 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Care Provider)
Primary Purpose:
Other
Official Title:
A Clinical Study on the Improvement of Sleep Quality, Skin Condition and Life Status After Taking Sleep Aid Drinks
Actual Study Start Date :
Jul 9, 2022
Actual Primary Completion Date :
Aug 7, 2022
Actual Study Completion Date :
Aug 7, 2022

Arms and Interventions

Arm Intervention/Treatment
Experimental: Experimental Group

Take drinks with active ingredients such as poria and GABA. Drink half an hour before bedtime, 10ml/bag/day, daily.

Combination Product: Drinks with active ingredients such as poria and GABA
Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.

Placebo Comparator: Control product group

Take a control drink that does not contain GABA and poria. Drink half an hour before bedtime, 10ml/bag/day, daily.

Combination Product: Drinks with active ingredients such as poria and GABA
Take drinks half an hour before bedtime, 10ml/bag/day, daily. Subjects are uniformly using skin care products provided by the sponsor during the test.

Outcome Measures

Primary Outcome Measures

  1. Changes in the Pittsburgh Sleep Quality Index [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline PSQI index at 2 weeks by questionnaire. Obtain change from Baseline PSQI index at 4 weeks by questionnaire.

  2. Changes in the sleep duration [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline sleep duration at 2 weeks by sleep quality monitoring bracelet. Obtain change from Baseline sleep duration at 4 weeks by sleep quality monitoring bracelet.

  3. Sleep Quality Assessment after 2-week application [Week2]

    Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire

  4. Sleep Quality Assessment after 4-week application [Week4]

    Obtain data on agreement with sleep improvement by sleep quality self-assessment questionnaire

Secondary Outcome Measures

  1. Changes in the skin hydration [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline skin hydration at 2 weeks by Corneometer. Obtain change from Baseline skin hydration at 4 weeks by Corneometer.

  2. Changes in the skin glossiness [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline skin glossiness at 2 weeks by Glossymeter. Obtain change from Baseline skin glossiness at 4 weeks by Glossymeter.

  3. Changes in the skin firmness [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline skin firmness at 2 weeks by cutometer. Obtain change from Baseline skin firmness at 4 weeks by cutometer.

  4. Changes in the skin elasticity [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline skin elasticity at 2 weeks by cutometer. Obtain change from Baseline skin elasticity at 4 weeks by cutometer.

  5. Changes in the individual type angle [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline Individual type angle at 2 weeks by Colorimeter. Obtain change from Baseline Individual type angle at 4 weeks by Colorimeter.

  6. Changes in the proportion of crow's feet area [Week0(Baseline)、Week2、Week4]

    Calculate the proportion of crow's feet area by Visia CR images. Obtain change from Baseline proportion of crow's feet area at 2 weeks. Obtain change from Baseline proportion of crow's feet area at 4 weeks.

  7. Changes in the proportion of fine lines under the eye [Week0(Baseline)、Week2、Week4]

    Calculate the proportion of fine lines under the eye by Visia CR images. Obtain change from Baseline proportion of fine lines under the eye at 2 weeks. Obtain change from Baseline proportion of fine lines under the eye at 4 weeks.

  8. Changes in the degree of wrinkle severity [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline degree of wrinkle severity at 2 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type. Obtain change from Baseline degree of wrinkle severity at 4 weeks by Dermatologist evaluation according to Skin Aging ATLAS of Asian Type.

  9. Changes in the grade of skin dryness [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline grade of skin dryness at 2 weeks by Dermatologist evaluation according to 5-point dryness scale. Obtain change from Baseline grade of skin dryness at 4 weeks by Dermatologist evaluation according to 5-point dryness scale.

  10. Changes in the CIE RGB of skin tone [Week0(Baseline)、Week2、Week4]

    Dermatologist use PANTONE SkinTone (Pantone color card) skin color guide to evaluate skin tone grade of subjects. Find the CIE RGB corresponding to the skin tone grade in Pantone ColorManager software and convert it into a color value using the formula for data analysis: CIE RGB = R+G*256+B*256*256. Calculate the change from Baseline CIE RGB of skin tone at 2 weeks. Calculate the change from Baseline CIE RGB of skin tone at 4 weeks.

  11. Skin condition Assessment after 2-week application [Week2]

    Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire

  12. Skin condition Assessment after 4-week application [Week4]

    Obtain data on agreement with skin condition improvement by skin condition self-assessment questionnaire

  13. Changes in the satisfaction with the quality of life [Week0(Baseline)、Week2、Week4]

    Obtain change from Baseline satisfaction with the quality of life at 2 weeks accessed by WHOQOL-100 questionnaire. Obtain change from Baseline satisfaction with the quality of life at 4 weeks accessed by WHOQOL-100 questionnaire.

Eligibility Criteria

Criteria

Ages Eligible for Study:
25 Years to 55 Years
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
Yes
Inclusion Criteria:
  1. 25-55 years old, Chinese female;

  2. PSQI index ≥ 7 (presence of sleep disorders);

  3. The subject's self-reported facial problems such as dryness, roughness, dullness, and lack of elasticity;

  4. The BMI of the subjects was between 18~24kg/m2;

  5. After the doctor's clinical evaluation, there are mild facial skin roughness (1 point and above) and mild to moderate overall facial wrinkles (3~6 points);

  6. Corneometer base measurement of facial skin moisture in 15~45 (Corneometer Unit, C.U.) Between;

  7. Have basic Chinese reading ability;

  8. can use smartphones;

  9. Be in good health and free of any other chronic diseases other than skin problems and sleep disorders or diseases being treated;

  10. Voluntarily participate in the test and sign the informed consent form; 11) Willingness to comply with all evaluation requirements;

Exclusion Criteria:
  1. Products with anti-wrinkle, firming, repairing and nourishing effects are not included in the skin care products used;

  2. Intend to become pregnant, or are pregnant or breastfeeding;

  3. Have a history of alcoholism;

  4. Have a history of allergies;

  5. Participated in any clinical trial evaluation within 1 month;

  6. Those who have applied any anti-inflammatory drugs to the test site within the past two months;

  7. Those who have suffered from skin diseases (such as psoriasis, eczema, psoriasis, skin cancer, etc.);

  8. patients with insulin-dependent diabetes;

  9. Patients with asthma or other chronic respiratory diseases who are being treated;

  10. Have taken/injected anti-allergic drugs in the past 1 month;

  11. Patients who have received anti-cancer chemotherapy or immunotherapy patients within the past 6 months;

  12. Have any other health problems or chronic diseases;

  13. Applying retinoids, A hydroxy acids, salicylic acids, hydroquinone within the past 3 months, or prescription drugs (antibiotics, retinoids, A hydroxy acids and steroids) in use within the past 6 months, oral contraceptives (if you have been taking the same contraceptive pills for the past 6 months, you can continue to take them);

  14. Experts or professionals believe that there are other iatrogenic reasons that will affect the evaluation results; 15) Those who have undergone surgery, plastic surgery or organ transplantation in the past year.

Contacts and Locations

Locations

Site City State Country Postal Code
1 Shanghai China-norm Quality Technical Service Co ,Ltd Shanghai Shanghai China 200000

Sponsors and Collaborators

  • Botanee Group Co., Ltd.

Investigators

  • Principal Investigator: Song Weiming, Master, Yan Shu Medical Beauty Chain Group

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Botanee Group Co., Ltd.
ClinicalTrials.gov Identifier:
NCT05908903
Other Study ID Numbers:
  • Botanee
First Posted:
Jun 18, 2023
Last Update Posted:
Jun 18, 2023
Last Verified:
Jun 1, 2023
Individual Participant Data (IPD) Sharing Statement:
No
Plan to Share IPD:
No
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Botanee Group Co., Ltd.
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 18, 2023